We speak at the 7th General Meeting of the JBA Drug Discovery Modality Platform Research Group：2025-07-11

PtBio Inc. will be presenting at the 7th General Meeting of the JBA Drug Discovery Modality Platform Research Group, titled “Deepening and Evolving Drug Discovery Modalities through Innovation and Integration”, to be held on July 18, 2025.

The General Meeting will include a report on the group’s activities for fiscal year 2024, an overview of this year’s activity policy, a seminar by Dr. Akitsu Hotta of the Center for iPS Cell Research and Application (CiRA), Kyoto University, and pitch presentations by newly joined member companies.

We will participate in the pitch presentation segment for member companies. We will introduce our proprietary genome editing technology, Zinc Finger-ND1, and discuss its applications in the development of drug discovery pipelines and antibody-producing cells.

We look forward to meeting all participants at the event.

■Event Overview

7th General Meeting of the JBA Drug Discovery Modality Platform Research Group

“Deepening and Evolving Drug Discovery Modalities through Innovation and Integration”

Date & Time: Friday, July 18, 2025 | 14:30～17:00

Format: Hybrid meeting via Zoom and in-person at the JBA office (Participation limited to research group and WG members)

Organizer: Japan Bioindustry Association (JBA) – Drug Discovery Modality Platform Research Group

Official Website: https://www.jba.or.jp/event/JBA_MODA_ZENTAIKAI_2025/